From Yahoo Finance: 2025-05-14 06:50:00

Wall Street indices saw a mixed finish on Tuesday, reacting to lower-than-expected inflation figures. The Consumer Price Index for April rose by 0.2%, bringing the annual inflation rate to 2.3%. Only the S&P 500 and Nasdaq gained, while the Dow Jones fell. BridgeBio Pharma, Inc. (BBIO) dropped 6.78% to $33.26 following Trump’s executive order on drug prices. The company widened its net loss by 371% to $169.6 million in Q1 with revenues falling by 45% to $116 million. BBIO ranks 8th among worst performers, with concerns about the impact of the new order on drugmakers’ profits.



Read more at Yahoo Finance: Why BridgeBio Pharma, Inc. (BBIO) Declined on Tuesday